Skip to main content

Politicians make promises on their stump — we watch and hold them accountable.

Help keep the record honest →Create an account
Bills/119th Congress · House

H.R. 8528

Introduced

PI Post Acute Access Act

Sponsor
RAdrian Smith· Nebraska
Introduced
April 27, 2026
Policy area
Health
Latest action
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.April 27, 2026
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8528 Introduced in House (IH)]

<DOC>

119th CONGRESS
2d Session
H. R. 8528

To amend title XVIII of the Social Security Act to improve access to 
skilled nursing facilities for primary immunodeficiency patients.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

April 27, 2026

Mr. Smith of Nebraska (for himself and Ms. Matsui) introduced the 
following bill; which was referred to the Committee on Ways and Means, 
and in addition to the Committee on Energy and Commerce, for a period 
to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
committee concerned

_______________________________________________________________________

A BILL

To amend title XVIII of the Social Security Act to improve access to 
skilled nursing facilities for primary immunodeficiency patients.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``PI Post Acute Access Act''.

SEC. 2. IMPROVING ACCESS TO SKILLED NURSING FACILITY SERVICES FOR 
PRIMARY IMMUNODEFICIENCY PATIENTS.

(a) In General.--Section 1888(e)(2)(A)(iii) of the Social Security 
Act (42 U.S.C. 1395yy(e)(2)(A)(iii)) is amended by adding at the end 
the following new subclause:
``(VII) Intravenous immune globulin 
indicated for the treatment of primary 
immune deficiency disease (identified 
as of January 1, 2026, by HCPCS codes 
J1561, J1569, J1576, J1568, J1459, 
J1554, J1557, J1566, and as 
subsequently modified by the Secretary) 
and items and services related to the 
furnishing of such globulin.''.
(b) Effective Date.--The amendment made by subsection (a) shall 
apply to items and services furnished on or after October 1, 2026.
<all>

Plain-language analysis

Not yet analyzed.

A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately and reviewed before publishing. It will appear here once ready. Until then, the verbatim text above and the official source are the record.

StumpWatch is live, and the record is still growing. Many promises and positions aren’t tracked yet, and some features are still in beta. Add a sourced promise and help keep the record honest.

Help keep the record honest →